Oncotarget

Vol 9, No 40

May 25, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 40 of Oncotarget features Figure 7, "Fap1-inhibition with SLV peptide increases Fas and Gsk3β phosphorylation in CD133+ cells in a murine xenograft model," by Huang, et al.

Table of Contents

Research Papers: Immunology

Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine

Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine

https://doi.org/10.18632/oncotarget.25399

Eita Sasaki, Haruka Momose, Yuki Hiradate, Keiko Furuhata, Takuo Mizukami,  and Isao Hamaguchi
25751-25763
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Research Papers

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma

https://doi.org/10.18632/oncotarget.25359

De-Xiu Bu, Reshma Singh, Eugene E. Choi, Marco Ruella, Selene Nunez-Cruz, Keith G. Mansfield, Paul Bennett, Nathanial Barton, Qilong Wu, Jiquan Zhang, Yongqiang Wang, Lai Wei, Shawn Cogan, Tucker Ezell, Shree Joshi, Kellie J. Latimer, Brian Granda, William R. Tschantz, Regina M. Young, Heather A. Huet, Celeste J. Richardson,  and Michael C. Milone
25764-25780
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Suppression of focal adhesion formation may account for the suppression of cell migration, invasion and growth of non-small cell lung cancer cells following treatment with polyisoprenylated cysteinyl amide inhibitors

Suppression of focal adhesion formation may account for the suppression of cell migration, invasion and growth of non-small cell lung cancer cells following treatment with polyisoprenylated cysteinyl amide inhibitors

https://doi.org/10.18632/oncotarget.25372

Elizabeth Ntantie, Michaela J. Allen, Jerrine Fletcher, Augustine T. Nkembo, Nazarius S. Lamango,  and Offiong F. Ikpatt
25781-25795
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells

Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells

https://doi.org/10.18632/oncotarget.25376

David W. Wolff, Min-Hyung Lee, Mathivanan Jothi, Munmun Mal, Fengzhi Li,  and Asoke K. Mal
25796-25807
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response

Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response

https://doi.org/10.18632/oncotarget.25380

Felipe V. Pereira, Amanda Campelo L. Melo, Jun Siong Low, Íris Arantes de Castro, Tárcio T. Braga, Danilo C. Almeida, Ana Gabriela U. Batista de Lima, Meire I. Hiyane, Matheus Correa-Costa, Vinicius Andrade-Oliveira, Clarice S.T. Origassa, Rosana M. Pereira, Susan M. Kaech, Elaine G. Rodrigues,  and Niels Olsen S. Câmara
25808-25825
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical validation of the Tempus xO assay

Clinical validation of the Tempus xO assay

https://doi.org/10.18632/oncotarget.25381

Nike Beaubier, Robert Tell, Robert Huether, Martin Bontrager, Stephen Bush, Jerod Parsons, Kaanan Shah, Tim Baker, Gene Selkov, Tim Taxter, Amber Thomas, Sam Bettis, Aly Khan, Denise Lau, Christina Lee, Matthew Barber, Marcin Cieslik, Casey Frankenberger, Amy Franzen, Ali Weiner, Gary Palmer, Robert Lonigro, Dan Robinson, Yi-Mi Wu, Xuhong Cao, Eric Lefkofsky, Arul Chinnaiyan,  and Kevin P. White
25826-25832
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells

VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells

https://doi.org/10.18632/oncotarget.25383

Atif J. Khan, Sarah M. Misenko, Aditya Thandoni, Devora Schiff, Sachin R. Jhawar, Samuel F. Bunting,  and Bruce G. Haffty
25833-25841
Abstract  |  PDF  |  HTML  |  Order a Reprint

Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics

Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics

https://doi.org/10.18632/oncotarget.25386

Sabrina Noack, Monika Raab, Yves Matthess, Mourad Sanhaji, Andrea Krämer, Balázs Győrffy, Lars Kaderali, Ahmed El-Balat, Sven Becker,  and Klaus Strebhardt
25842-25859
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients

Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients

https://doi.org/10.18632/oncotarget.25395

Sascha Marx, Maximilian Splittstöhser, Frederik Kinnen, Eileen Moritz, Christy Joseph, Sebastian Paul, Heiko Paland, Carolin Seifert, Madlen Marx, Andreas Böhm, Edzard Schwedhelm, Kerstin Holzer, Stephan Singer, Christoph A. Ritter, Sandra Bien-Möller, Henry W.S. Schroeder,  and Bernhard H. Rauch
25860-25876
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent

Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent

https://doi.org/10.18632/oncotarget.25398

Antonella Rigo, Isacco Ferrarini, Angela Bonalumi, Cristina Tecchio, Alessio Montresor, Carlo Laudanna,  and Fabrizio Vinante
25877-25890
Abstract  |  PDF  |  HTML  |  Order a Reprint

Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin

Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin

https://doi.org/10.18632/oncotarget.25401

Weiqi Huang, Ling Bei,  and Elizabeth A. Eklund
25891-25902
Abstract  |  PDF  |  HTML  |  Order a Reprint

CHL1 gene acts as a tumor suppressor in human neuroblastoma

CHL1 gene acts as a tumor suppressor in human neuroblastoma

https://doi.org/10.18632/oncotarget.25403

Marzia Ognibene, Gabriella Pagnan, Danilo Marimpietri, Davide Cangelosi, Michele Cilli, Maria Chiara Benedetti, Renata Boldrini, Alberto Garaventa, Francesco Frassoni, Alessandra Eva, Luigi Varesio, Vito Pistoia,  and Annalisa Pezzolo
25903-25921
Abstract  |  PDF  |  HTML  |  Order a Reprint

Epigenetic dysregulation of TET2 in human glioblastoma

Epigenetic dysregulation of TET2 in human glioblastoma

https://doi.org/10.18632/oncotarget.25406

María G. García, Antonella Carella, Rocío G. Urdinguio, Gustavo F. Bayón, Virginia Lopez, Juan Ramón Tejedor, Marta I. Sierra, Estela García-Toraño, Pablo Santamarina, Raúl F. Perez, Cristina Mangas, Aurora Astudillo, M. Daniela Corte-Torres, Inés Sáenz-de-Santa-María, María-Dolores Chiara, Agustín F. Fernández,  and Mario F. Fraga
25922-25934
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening

https://doi.org/10.18632/oncotarget.25407

Sebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, Markus Eckstein, Annette Steidler, Cleo Aaron Weiss, Christian Bolenz, Arndt Hartmann,  and Philipp Erben
25935-25945
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients

Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients

https://doi.org/10.18632/oncotarget.25408

Stewart G. Martin, Marie N. Lebot, Bhudsaban Sukkarn, Graham Ball, Andrew R. Green, Emad A. Rakha, Ian O. Ellis,  and Sarah J. Storr
25946-25956
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Targeted DNA sequencing of non-small cell lung cancer identifies mutations associated with brain metastases

Targeted DNA sequencing of non-small cell lung cancer identifies mutations associated with brain metastases

https://doi.org/10.18632/oncotarget.25409

George D. Wilson, Matthew D. Johnson, Samreen Ahmed, Paola Yumpo Cardenas, Inga S. Grills,  and Bryan J. Thibodeau
25957-25970
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions

Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions

https://doi.org/10.18632/oncotarget.25411

Agata Pastorczak, Lukasz Sedek, Marcin Braun, Joanna Madzio, Alicja Sonsala, Magdalena Twardoch, Wojciech Fendler, Karin Nebral, Joanna Taha, Marta Bielska, Patryk Gorniak, Magdalena Romiszewska, Michal Matysiak, Katarzyna Derwich, Monika Lejman, Jerzy Kowalczyk, Wanda Badowska, Maciej Niedzwiecki, Bernarda Kazanowska, Katarzyna Muszynska-Roslan, Grazyna Sobol-Milejska, Grazyna Karolczyk, Andrzej Koltan, Tomasz Ociepa, Tomasz Szczepanski,  and Wojciech Młynarski
25971-25982
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Activated matriptase as a target to treat breast cancer with a drug conjugate

Activated matriptase as a target to treat breast cancer with a drug conjugate

https://doi.org/10.18632/oncotarget.25414

Gulam M. Rather, Siang-Yo Lin, Hongxia Lin, Whitney Banach-Petrosky, Kim M. Hirshfield, Chen-Yong Lin, Michael D. Johnson, Zoltan Szekely,  and Joseph R. Bertino
25983-25992
Abstract  |  PDF  |  HTML  |  Order a Reprint

Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma

Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma

https://doi.org/10.18632/oncotarget.25417

Atsushi Shiozaki, Shoichiro Hikami, Daisuke Ichikawa, Toshiyuki Kosuga, Hiroki Shimizu, Michihiro Kudou, Yuzo Yamazato, Toshiyuki Kobayashi, Katsutoshi Shoda, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Takeshi Kubota, Hitoshi Fujiwara, Kazuma Okamoto, Mitsuo Kishimoto, Eiichi Konishi, Yoshinori Marunaka,  and Eigo Otsuji
25993-26006
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Impact of aldosterone-producing cell clusters on diagnostic discrepancies in primary aldosteronism

Impact of aldosterone-producing cell clusters on diagnostic discrepancies in primary aldosteronism

https://doi.org/10.18632/oncotarget.25418

Mitsuhiro Kometani, Takashi Yoneda, Daisuke Aono, Shigehiro Karashima, Masashi Demura, Koshiro Nishimoto, Masakazu Yamagishi,  and Yoshiyu Takeda
26007-26018
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia

A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia

https://doi.org/10.18632/oncotarget.25419

Daniel Primo, Lydia Scarfò, Aliki Xochelli, Mattias Mattsson, Pamela Ranghetti, Ana Belén Espinosa, Alicia Robles, Julian Gorrochategui, Joaquín Martínez-López, Javier de la Serna, Marcos González, Alberto Chaparro Gil, Eduardo Anguita, Sandra Iraheta, Veerendra Munugalavadla, Christophe Quéva, Stacey Tannheimer, Richard Rosenquist, Kostas Stamatopoulos, Joan Ballesteros,  and Paolo Ghia
26019-26031
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128

CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128

https://doi.org/10.18632/oncotarget.25430

Mohamed Badawi, Jihye Kim, Anees Dauki, Dhruvitkumar Sutaria, Tasneem Motiwala, Ryan Reyes, Nissar Wani, Shamalatha Kolli, Jinmai Jiang, Christopher C. Coss, Samson T. Jacob, Mitch A. Phelps,  and Thomas D. Schmittgen
26032-26045
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose

BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose

https://doi.org/10.18632/oncotarget.25433

Federico Lucantoni, Heiko Düssmann, Irene Llorente-Folch,  and Jochen H.M. Prehn
26046-26063
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines

High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines

https://doi.org/10.18632/oncotarget.25436

Farhad Ghasemi, Morgan Black, Ren X. Sun, Frederick Vizeacoumar, Nicole Pinto, Kara M. Ruicci, John Yoo, Kevin Fung, Danielle MacNeil, David A. Palma, Eric Winquist, Joe S. Mymryk, Laurie A. Ailles, Alessandro Datti, John W. Barrett, Paul C. Boutros,  and Anthony C. Nichols
26064-26071
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells

Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells

https://doi.org/10.18632/oncotarget.25437

Martin C. Pearce, John T. Gamble, Prasad R. Kopparapu, Edmond F. O'Donnell, Monica J. Mueller, Hyo Sang Jang, Julie A. Greenwood, Arnold C. Satterthwait, Roberta L. Tanguay, Xiao-Kun Zhang,  and Siva Kumar Kolluri
26072-26085
Abstract  |  PDF  |  HTML  |  Order a Reprint

Twenty-seven-nucleotide repeat insertion in the rplV gene confers specific resistance to macrolide antibiotics in Staphylococcus aureus

Twenty-seven-nucleotide repeat insertion in the rplV gene confers specific resistance to macrolide antibiotics in Staphylococcus aureus

https://doi.org/10.18632/oncotarget.25441

Dianpeng Han, Yu Liu, Jingjing Li, Chenghua Liu, Yaping Gao, Jiannan Feng, Huizhe Lu,  and Guang Yang
26086-26095
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A novel combinatorial treatment option for metastatic uveal melanoma

A novel combinatorial treatment option for metastatic uveal melanoma

https://doi.org/10.18632/oncotarget.25445

Dudi Shneor, Shay Tayeb, Jacob Pe'er, Hanna Voropaev, Maria Gimmelshein, Nathalie Cassoux, Alik Honigman,  and Shahar Frenkel
26096-26108
Abstract  |  PDF  |  HTML  |  Order a Reprint

Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models

Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models

https://doi.org/10.18632/oncotarget.25450

Surendra R. Punganuru, Hanumantha Rao Madala, Constantinos M. Mikelis, Anshuman Dixit, Viswanath Arutla,  and Kalkunte S. Srivenugopal
26109-26129
Abstract  |  PDF  |  HTML  |  Order a Reprint

Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity

Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity

https://doi.org/10.18632/oncotarget.25452

Kuan Chai, Xuerao Ning, Thảo Thi Thanh Nguyễn, Boya Zhong, Takao Morinaga, Zhihan Li, Masato Shingyoji, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima, Naoto Yamaguchi,  and Masatoshi Tagawa
26130-26143
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Loss-of-function mutations in Zn-finger DNA-binding domain of HNF4A cause aberrant transcriptional regulation in liver cancer

Loss-of-function mutations in Zn-finger DNA-binding domain of HNF4A cause aberrant transcriptional regulation in liver cancer

https://doi.org/10.18632/oncotarget.25456

Hiroaki Taniguchi, Akihiro Fujimoto, Hidetoshi Kono, Mayuko Furuta, Masashi Fujita,  and Hidewaki Nakagawa
26144-26156
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Lymph microvascularization as a prognostic indicator in neuroblastoma

Lymph microvascularization as a prognostic indicator in neuroblastoma

https://doi.org/10.18632/oncotarget.25457

Irene Tadeo, Esther Gamero-Sandemetrio, Ana P. Berbegall, Marta Gironella, Félix Ritort, Adela Cañete, Gloria Bueno, Samuel Navarro,  and Rosa Noguera
26157-26170
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Translation termination-dependent deadenylation of MYC mRNA in human cells

Translation termination-dependent deadenylation of MYC mRNA in human cells

https://doi.org/10.18632/oncotarget.25459

Béatrice Jolles, Affaf Aliouat, Vérène Stierlé, Samia Salhi,  and Olivier Jean-Jean
26171-26182
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Association of mRNA expression of iron metabolism-associated genes and progression of non-alcoholic steatohepatitis in rats

Association of mRNA expression of iron metabolism-associated genes and progression of non-alcoholic steatohepatitis in rats

https://doi.org/10.18632/oncotarget.25488

Teruhisa Higuchi, Mitsuhiko Moriyama, Akiko Fukushima, Hiroshi Matsumura, Shunichi Matsuoka, Tatsuo Kanda, Masahiko Sugitani, Akiko Tsunemi, Takahiro Ueno,  and Noboru Fukuda
26183-26194
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment

Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment

https://doi.org/10.18632/oncotarget.25490

Jan Nyrop Jakobsen, Eric Santoni-Rugiu, Morten Grauslund, Linea Melchior,  and Jens Benn Sørensen
26195-26208
Abstract  |  PDF  |  HTML  |  Order a Reprint

Clinical Research Papers

Diffusion-weighted MRI in the evaluation of the thyroid nodule: Comparison between integrated-shimming EPI and conventional 3D-shimming EPI techniques

Diffusion-weighted MRI in the evaluation of the thyroid nodule: Comparison between integrated-shimming EPI and conventional 3D-shimming EPI techniques

https://doi.org/10.18632/oncotarget.25279

Luguang Chen, Peipei Sun, Qiang Hao, Wei Yin, Bing Xu, Chao Ma, Alto Stemmer, Caixia Fu, Minjie Wang,  and Jianping Lu
26209-26216
Abstract  |  PDF  |  HTML  |  Order a Reprint

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians

https://doi.org/10.18632/oncotarget.25439

Katharina C. Kähler, Christine Blome, Andrea Forschner, Ralf Gutzmer, Axel Hauschild, Lucie Heinzerling, Elisabeth Livingstone, Carmen Loquai, Tina Müller-Brenne, Dirk Schadendorf, Jochen Utikal, Tobias Wagner,  and Matthias Augustin
26217-26225
Abstract  |  PDF  |  HTML  |  Order a Reprint

Reviews

Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models

Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models

https://doi.org/10.18632/oncotarget.25360

Ravi Salgia, Isa Mambetsariev, Blake Hewelt, Srisairam Achuthan, Haiqing Li, Valeriy Poroyko, Yingyu Wang,  and Martin Sattler
26226-26242
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger–containing 1 (UHRF1) for anti-cancer drug development

Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger–containing 1 (UHRF1) for anti-cancer drug development

https://doi.org/10.18632/oncotarget.25425

Debasis Patnaik, Pierre-Olivier Estève,  and Sriharsa Pradhan
26243-26258
Abstract  |  PDF  |  HTML  |  Order a Reprint

Role of p27Kip1 as a transcriptional regulator

Role of p27Kip1 as a transcriptional regulator

https://doi.org/10.18632/oncotarget.25447

Oriol Bachs, Edurne Gallastegui, Serena Orlando, Anna Bigas, José Manuel Morante-Redolat, Joan Serratosa, Isabel Fariñas, Rosa Aligué,  and Maria Jesús Pujol
26259-26278
Abstract  |  PDF  |  HTML  |  Order a Reprint


Copyright © 2018 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC